Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
Open-market buys, last 90 days
$58,826
in 14 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$58,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Equels Thomas K +$59K CEO & President 14 filings

Reading 64 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-06-05 MITCHELL WILLIAM M Director Other acquisition · Options to buy Common Stock +100,000 412,000
2012-06-05 PIANI RICHARD Director Other acquisition · Options to buy Common Stock +100,000 424,608
2012-06-05 Equels Thomas K. Exec Vice Chairman of Board Other acquisition · Options to buy Common Stock +100,000 700,000
2012-06-05 CARTER WILLIAM A CEO Other acquisition · Options to buy Common Stock +100,000 6,865,378
2012-06-05 Springate Wayne S. Senior VP of Operations Other acquisition · Options to buy Common Stock +50,000 188,900
2012-06-05 Dickey Robert IV Senior Vice President Other acquisition · Options to Buy Common Stock +50,000 200,000
2012-05-18 STRAYER DAVID R Medical Director Purchase +44,900 $0.26 $11K 280,932
2012-05-17 STRAYER DAVID R Medical Director Purchase +5,100 $0.26 $1K 236,032
2012-05-10 KIANI IRAJ EGHBAL Director Other acquisition +11,062 $2.26 $25K 257,333
2012-05-10 KIANI IRAJ EGHBAL Director Other acquisition +5,208 $2.40 $12K 262,541
2012-04-13 STRAYER DAVID R Medical Director Other acquisition · Options to buy Common Stock +10,000 190,000
2012-04-13 CARTER WILLIAM A CEO Other acquisition · Options to buy Common Stock +10,000 6,765,378
2011-12-22 Bernhardt Charles Thomas III Chief Financial Officer Other acquisition · Options to buy Common Stock +100,000 200,000
2011-09-23 Cavalli Ralph Christopher VP, Quality Control Other acquisition · Options to buy Common Stock +40,000 60,000
2011-07-15 CARTER WILLIAM A CEO Other acquisition · Options to buy Common Stock +500,000 7,256,574
2011-06-24 Equels Thomas K. General Counsel Other acquisition · Options to buy Common Stock +300,000 1,091,196
2011-05-31 Springate Wayne S. VP of Operations Purchase · Options to buy Common Stock +90,000 138,900
2011-03-01 Lander Russel J VP of Process/QualityAssurance Purchase +25,000 $0.46 $12K 182,983
2011-03-01 Lander Russel J VP of Process/QualityAssurance Purchase +25,000 $0.46 $11K 207,983
2010-12-22 CARTER WILLIAM A CEO Purchase · Options to buy Common Stock +73,728 6,756,574

Page 27 of 33 · 653 trades